Robert J. Motzer, MD - Advanced Renal Cell Carcinoma: Clinical Advances in Approaches to Combination Therapy

Visit https://www.peervoice.com/SAU860 to view the entire programme with slides. After completing “Robert J. Motzer, MD - Advanced Renal Cell Carcinoma: Clinical Advances in Approaches to Combination Therapy”, participants will be able to: Evaluate the available safety and efficacy data from trials examining current and emerging therapies, including combination regimens, in advanced renal cell carcinoma (RCC); Identify and assess adverse events (AEs) associated with combination therapy in patients with advanced RCC; and Apply recommended strategies and incorporate patient preferences in the management of AEs associated with combination therapy in advanced RCC.